Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.

Journal of inherited metabolic disease - 1 Sept 2000

Van Hove J L, Kahler S G, Feezor M D, Ramakrishna J P, Hart P, Treem W R, Shen J J, Matern D, Millington D S

Abstract excerpt

The acylcarnitines in plasma and blood spots of 23 patients with proven deficiency of long-chain 3-hydroxyacylcoenzyme A dehydrogenase were reviewed. Long-chain 3-hydroxyacylcarnitines of C14:1, C14, C16 and C18:1 chain length, and long-chain acylcarnitines of C12, C14:1, C14, C16, C18:2 and C18:1 chain length were elevated. Acetylcarnitine was decreased. In plasma, elevation of hydroxy-C18:1 acylcarnitine over...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Hydroxyacyl CoA Dehydrogenases
Share to Carnitine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Erythrocytes

Share to False Negative Reactions

Share to Heterozygote

Share to Homozygote

Share to Plasma

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 11032332
DOI: 10.1023/a:1005673828469

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.PMID 11032332Read ↗

Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.Semantic proximity Read ↗

Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD).Semantic proximity Read ↗

The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).Semantic proximity Read ↗

Clinical and biochemical features of fatty acid oxidation disorders.Semantic proximity Read ↗

Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.Semantic proximity Read ↗

Short-chain acyl-coenzyme A dehydrogenase deficiency.Semantic proximity Read ↗

Medium-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.Semantic proximity Read ↗

Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.Semantic proximity Read ↗

Molecular analysis of medium-chain acyl-CoA dehydrogenase deficiency: a diagnostic approach.Semantic proximity Read ↗

Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?Semantic proximity Read ↗

[Short chain acyl-CoA dehydrogenase deficiency].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.